Search - Centre de recherche en cancérologie Nantes-Angers Unité Mixte de Recherche 892 Inserm - 6299 CNRS Access content directly

Filter your results

1 Résultat
authFullName_s : David Perol

Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

S. Delaloge , David Perol , C. Courtinard , E. Brain , B. Asselain , et al.
Annals of Oncology, 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩
Journal articles hal-02262350v1